AMI Corporation Selected for NEDO Deep Tech Startup Support Program

AMI Corporation Selected for NEDO's Deep Tech Startup Support Program

AMI Corporation, based in Kagoshima and with a branch in Kumamoto, has recently received approval from the New Energy and Industrial Technology Development Organization (NEDO) for its proposal under the "Deep Tech Startup Support Fund." This initiative aims to accelerate the development of technologies that address significant social challenges.

Mission of AMI Corporation

The mission of AMI Corporation is to enable high-quality medical care accessible to everyone at any time and place. With the selection for NEDO’s funding, AMI aims to leverage AI technology to enhance the precision of digital biomarkers pertaining to heart sounds, develop new solutions, and establish expansive data infrastructure. This is part of a broader effort to counteract the serious societal issues of undetected heart diseases and to facilitate early diagnosis.

Strategic Objectives

The financial support from NEDO will contribute to the following goals:

- Improving Heart Sound Digital Biomarkers: By utilizing cutting-edge AI technology, AMI intends to refine and innovate heart sound analysis for better diagnostic accuracy.
- Building a Comprehensive Data Framework: Establishing a large-scale data foundation is crucial for conducting reliable and extensive research. This will support effective solutions in combating heart conditions globally.
- Accelerating Technology Pilot Tests Abroad: AMI plans to validate its technologies in international markets, thereby paving the way for broader acceptance and implementation of its medical innovations.

As part of its commitment to fostering innovation, AMI is actively recruiting key personnel, including medical researchers, engineers, data scientists, and business development professionals. If you are interested in the intersection of healthcare, AI, and startup culture, AMI welcomes you to join them in shaping the future of medical care.

About NEDO's Deep Tech Startup Support

NEDO's program is designed to assist startups engaging in long-term research and development with high risks that ultimately contribute to solving economic and social issues such as carbon neutrality and resource recycling. It involves three critical phases, which include:
1. STS Phase: Early-stage practical research and development.
2. PCA Phase: Late-stage practical research and development, focusing on the commercial viability of products and technologies.
3. DMP Phase: Demonstration of mass production capabilities.
The program allows startups to advance through these stages upon successful evaluation, ensuring continual support throughout their development journey.

About AMI Corporation

Founded in November 2015, AMI Corporation is at the forefront of developing advanced medical devices, including an innovative stethoscope equipped with AI-assisted diagnostic features. The company's goal is to transform healthcare delivery by integrating sound engineering, electronics, and AI technologies for telemedicine solutions. AMI believes in providing high-quality medical care to individuals whenever and wherever they may be.

For more information and insights into AMI Corporation’s initiatives, please check out their promotional video here.

Contact and Learn More

For inquiries regarding their services or recruitment, please visit AMI's official website at ami.inc. It's important to note that inquiries made through the site are intended for stakeholders and not for general medical advice.

Company Overview

- Name: AMI Corporation
- CEO: Shinpei Ogawa
- Established: November 2015
- Main Office: Kagoshima City, Kagoshima Prefecture
- Branch: Minamata City, Kumamoto Prefecture
- Services: Development of medical devices and telemedicine services.

Conclusion

AMI Corporation's participation in NEDO's program signifies a critical step forward in redefining healthcare through the integration of AI and telemedicine. The company's commitment to enhancing medical technology could revolutionize access to quality healthcare in the future.